Alloimmunization and autoimmunization in adult transfusion-dependent thalassemia patients: a report from a comprehensive center in Israel

[1]  C. Napoli,et al.  Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience. , 2019, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[2]  C. Josephson,et al.  Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline , 2018, Transfusion.

[3]  S. Kleinman,et al.  Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS‐III) database , 2018, British journal of haematology.

[4]  J. Hendrickson,et al.  Red Blood Cell Antibodies in Hematology/Oncology Patients: Interpretation of Immunohematologic Tests and Clinical Significance of Detected Antibodies. , 2016, Hematology/oncology clinics of North America.

[5]  K. Saad,et al.  Regulatory B cells (CD19(+)CD38(hi)CD24(hi)) in alloimmunized and non-alloimmunized children with β-thalassemia major. , 2016, Blood cells, molecules & diseases.

[6]  Z. Alfirevic,et al.  Red blood cell alloimmunization , 2016 .

[7]  N. Al-Allawi,et al.  Predictors of Red Cell Alloimmunization in Kurdish Multi Transfused Patients with Hemoglobinopathies in Iraq , 2015, Hemoglobin.

[8]  N. Marwaha,et al.  Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients , 2014, Asian journal of transfusion science.

[9]  B. Shaz,et al.  Red blood cell alloimmunization mitigation strategies. , 2014, Transfusion medicine reviews.

[10]  L. Pierelli,et al.  Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing , 2014, Vox sanguinis.

[11]  D. Ambruso.  Transfusion complications in thalassemias , 2014, Transfusion.

[12]  E. Neufeld,et al.  Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME) , 2014, Transfusion.

[13]  A. Verma,et al.  Red Blood Cell Antibodies in Thalassemia Patients in Northern India: Risk Factors and Literature Review , 2014, Indian Journal of Hematology and Blood Transfusion.

[14]  A. Thompson,et al.  Challenges of alloimmunization in patients with haemoglobinopathies , 2012, British journal of haematology.

[15]  Mohsen Saleh Elalfy,et al.  Red blood cell alloimmunization in transfusion‐dependent Egyptian patients with thalassemia in a limited donor exposure program , 2012, Transfusion.

[16]  S. Hmida,et al.  High frequency of autoimmunization among transfusion-dependent Tunisian thalassaemia patients. , 2011, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[17]  Richa Gupta,et al.  Alloimmunization to red cells in thalassemics: emerging problem and future strategies. , 2011, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[18]  E. Neufeld,et al.  Red cell alloimmunization in a diverse population of transfused patients with thalassaemia , 2011, British journal of haematology.

[19]  M. Pujani,et al.  Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin , 2010, Hematology.

[20]  Raffaella Origa,et al.  BETA THALASSEMIA , 2018, The Professional Medical Journal.

[21]  H. Rafatpanah,et al.  Alloimmunization among transfusion-dependent thalassemia patients , 2009, Asian journal of transfusion science.

[22]  N. Avent.  Large‐scale blood group genotyping – clinical implications , 2009, British journal of haematology.

[23]  C. Tormey,et al.  Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans , 2008, Transfusion.

[24]  M. Karimi,et al.  RBC alloimmunization in blood transfusion‐dependent β‐thalassemia patients in southern Iran , 2007, International journal of laboratory hematology.

[25]  D. Liang,et al.  Alloimmunization among patients with transfusion‐dependent thalassemia in Taiwan , 2006, Transfusion medicine.

[26]  A. Cnaan,et al.  Survival and Complications in Thalassemia , 2005, Annals of the New York Academy of Sciences.

[27]  E. Rachmilewitz,et al.  MEDICAL PROGRESS : β-thalassemia , 2005 .

[28]  D. Blackall,et al.  Warm reactive autoantibodies: clinical and serologic correlations. , 2004, American journal of clinical pathology.

[29]  S. Al-Shemmari,et al.  RBC alloimmunization and autoimmunization among transfusion‐dependent Arab thalassemia patients , 2003, Transfusion.

[30]  N. Blumberg,et al.  WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization , 2003, Transfusion.

[31]  E. Vichinsky,et al.  Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. , 2000, Blood.

[32]  N. Olivieri.  The β-Thalassemias , 1999 .

[33]  N. Olivieri.  The beta-thalassemias. , 1999, The New England journal of medicine.

[34]  L. Rybicki,et al.  Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. , 1995, Archives of pathology & laboratory medicine.

[35]  J. Peristeri,et al.  Red Cell Alloantibodies in Patients with Thalassemia , 1990, Vox sanguinis.

[36]  A. Zanella,et al.  Red cell alloantibodies in thalassemia major , 1985, Transfusion.